Feasibility study of the bi-weekly administration of eribulin for metastatic breast cancer
Not Applicable
Recruiting
- Conditions
- Metastatic breast cancer
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Patients with serious complications, a history of drug hypersensitivity, brain metastases with any symptoms, active secondary cancer, or pregnant women were excluded.
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ORR, overall response rate
- Secondary Outcome Measures
Name Time Method